Eagle flying as new team takes wing

Eagle, the Cambridge UK bioinformatics software and services business, has made several key appointments as it rolls out major initiatives in genomics research.

The scale-up follows significant developments for Eagle this year. It recently won a Small Business Research Initiative competition, which will see the company further develop its technology for genomic data management and analysis.

The competition was funded by the Department of Health, through the SBRI and managed by Genomics England, which supports the efforts to map 100,000 whole genomes of NHS patients with cancer or a rare disease by 2017.

As a winner of the first phase, Eagle has received a share of the 1.6 million fund available. This will be used to extend the capabilities of its existing technology platform, which has been developed to meet the demand for improved NGS technology in the healthcare sector.

Eagle, based at Babraham Research Campus, is propelling new opportunities in large scale omics data and its application to real world problems in health, wellness, food and environmental sectors.

The latest appointments include a new vice-president of global sales and internal promotions for the chief scientific officer and chief technical officer positions.

Michael Reynolds joins Eagle as VP of global sales while Will Spooner is promoted to chief scientific officer and Glenn Proctor to chief technical officer. The roles are part of Eagles ongoing growth, including a series of new customer wins and the development of a bioinformatics software platform for the intelligent sharing of genomic data and metadata, which will be launched later this year.

Reynolds has a wealth of sales and marketing experience to Eagle, along with a wide network of global contacts from a number of previous sales roles in the life science industry. Prior to Eagle, he was director, EMEA Sales, at Pilgrim Software, and prior roles included Smart Analyst, APC Pharma and Etrials.

A microbiologist by degree and a sales professional by choice, he has been working for major pharmaceutical companies or selling to life science and other organisations for more than 20 years.

Spooner moves into the newly created role of CSO where he will be responsible for ensuring that Eagle remains at the forefront of bioinformatics knowledge.

Excerpt from:
Eagle flying as new team takes wing